- Home
- SPLP vs BCYC Comparison
SPLP vs BCYC Comparison
Compare SPLP & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPLP
- BCYC
- Stock Information
- Founded
- SPLP 1990
- BCYC 2009
- Country
- SPLP United States
- BCYC United Kingdom
- Employees
- SPLP N/A
- BCYC N/A
- Industry
- SPLP Industrial Specialties
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- SPLP Industrials
- BCYC Health Care
- Exchange
- SPLP Nasdaq
- BCYC Nasdaq
- Market Cap
- SPLP 771.3M
- BCYC 896.2M
- IPO Year
- SPLP N/A
- BCYC 2019
- Fundamental
- Price
- SPLP $41.69
- BCYC $11.66
- Analyst Decision
- SPLP
- BCYC Buy
- Analyst Count
- SPLP 0
- BCYC 9
- Target Price
- SPLP N/A
- BCYC $33.25
- AVG Volume (30 Days)
- SPLP 784.0
- BCYC 275.5K
- Earning Date
- SPLP 03-07-2025
- BCYC 02-25-2025
- Dividend Yield
- SPLP N/A
- BCYC N/A
- EPS Growth
- SPLP 28.01
- BCYC N/A
- EPS
- SPLP 9.74
- BCYC N/A
- Revenue
- SPLP $1,996,835,000.00
- BCYC $36,898,000.00
- Revenue This Year
- SPLP N/A
- BCYC $41.07
- Revenue Next Year
- SPLP N/A
- BCYC N/A
- P/E Ratio
- SPLP $4.34
- BCYC N/A
- Revenue Growth
- SPLP 7.29
- BCYC 48.60
- 52 Week Low
- SPLP $34.55
- BCYC $11.14
- 52 Week High
- SPLP $48.45
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- SPLP 51.86
- BCYC 34.58
- Support Level
- SPLP $41.53
- BCYC $11.14
- Resistance Level
- SPLP $42.25
- BCYC $13.11
- Average True Range (ATR)
- SPLP 0.36
- BCYC 0.69
- MACD
- SPLP 0.18
- BCYC 0.08
- Stochastic Oscillator
- SPLP 56.94
- BCYC 22.32
About SPLP Steel Partners Holdings LP LTD PARTNERSHIP UNIT
Steel Partners Holdings LP operates in industrial products, energy, defense, supply chain management and logistics, banking, and youth sports industries. It operates in various segments including the Diversified Industrial segment comprised of manufacturers of engineered niche industrial products, including joining materials, tubing, building materials, performance materials, electrical products, cutting replacement products and services, and metallized films and packaging businesses; the Energy segment provides drilling and production services to the oil and gas industry and owns a youth sports business; the Financial Services segment consists of the operations of WebBank, a Utah chartered industrial bank, which engages in full range of banking activities.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.